26 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
clinical benefit, with all patients in remission or with major reductions in symptoms with a median follow up of 15 months. Toxic effects were manageable … administration of cytokines can be toxic, therefore we have developed programming modules that are designed to harness the enhanced activity of cytokines
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
,
toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, “Hazardous Materials
8-K
EX-10.1
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, “Hazardous Materials
10-Q
2023 Q3
EX-10.1
AUTL
Autolus Therapeutics plc
9 Nov 23
Quarterly report
4:18pm
or for sleeping or for residential purposes; 4.10.5 stand anything outside the Property; 4.10.6 cause or permit any toxic, contaminative, hazardous or dangerous
6-K
EX-1.1
AUTL
Autolus Therapeutics plc
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos
6-K
EX-99.1
3katdaptc7eq6pnr99dp
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-1
ogwnd nbh4is1i7mf81v
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1.1
u0rdyaa6
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
4efhbjxk
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
6-K
EX-1
weci x744wjumk
26 May 20
Current report (foreign)
4:31pm
6-K
EX-1.1
4yg3xx
24 Jan 20
Autolus Announces Proposed Public Offering in the United States
4:06pm
424B4
7lw1fg1yx rcdd
11 Apr 19
Prospectus supplement with pricing info
4:10pm
F-1
u7lxe 217jd0
8 Apr 19
Registration statement (foreign)
4:34pm
F-1
EX-1.1
8thksxw8h706q
8 Apr 19
Registration statement (foreign)
4:34pm
6-K
EX-1
8kc7ua4s
15 Mar 19
Annual Report and Accounts
5:26pm
20-F
5lx9rflm 69yfi
23 Nov 18
Annual report (foreign)
12:00am
DRS
ml9mu
23 Nov 18
Draft registration statement
12:00am